Merck Sharp & Dohme LLC 2025-12-31 Health serious FDA
Health · FDA · Recall #FDA-D-0241-2026
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only,… Recall
Issued December 31, 2025 · Merck Sharp & Dohme LLC
In December 2025, Merck Sharp & Dohme LLC recalled the Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of particulate matter: potential presence of metal particulates in the product.
What you should do
- 1 Stop using Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Merck Sharp & Dohme LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Merck Sharp & Dohme LLC
- Category
- Health
- Recall date
- December 31, 2025
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0241-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Merck Sharp & Dohme LLC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.